Melissa Sturgess
Chief Executive Officer Ananda Pharma
Seminars
Wednesday 15th October 2025
Panel Discussion: Explore How Industry Leaders are Navigating the Challenges of Bringing Cannabinoid Based Therapies to Women’s Health
4:00 pm
- Explore effective strategies to engage and educate patients, clinicians, and advocacy groups to drive awareness and increase participation in cannabinoid clinical trials for endometriosis.
- Identify the key regulatory, societal, and commercial barriers limiting patient access to cannabinoid-based therapies and evaluating solutions
- Examine how industry collaboration, policy evolution, and patient advocacy can work together to accelerate the responsible adoption of cannabinoid treatments in women’s health
Wednesday 15th October 2025
Advancing Botanical Cannabidiol Drugs: Insights Ffrom Endometriosis Clinical Development
3:00 pm
- Exploring a strategic approach to cannabidiol drug development that prioritizes the use of naturally derived CBD isolate and the associated advantages
- Discussing the rationale for utilizing higher doses over modifications to improve bioavailability to improve drug efficacy
- Examining Ananda’s endometriosis program as a case study to highlight the clinical and regulatory strategies that enabled fast progression into human trials and why this model is important for women’s health
